Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
- PMID: 37753346
- PMCID: PMC10519224
- DOI: 10.2147/HMER.S326468
Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
Abstract
Alcohol-associated liver disease (ALD) represents a major public health issue worldwide and is a leading etiology of liver cirrhosis. Alcohol-related liver injuries include a range of manifestations including alcoholic hepatitis (AH), simple steatosis, steatohepatitis, hepatic fibrosis, cirrhosis and liver cancer. Liver disease occurs from several pathological disturbances such as the metabolism of ethanol, which generates reactive oxygen species (ROS) in hepatocytes, alterations in the gut microbiota, and the immune response to these changes. A common hallmark of these liver affections is the establishment of an inflammatory environment, and some (broad) anti-inflammatory approaches are used to treat AH (eg, corticosteroids). Macrophages, which represent the main innate immune cells in the liver, respond to a wide variety of (pathogenic) stimuli and adopt a large spectrum of phenotypes. This translates to a diversity of functions including pathogen and debris clearance, recruitment of other immune cells, activation of fibroblasts, or tissue repair. Thus, macrophage populations play a crucial role in the course of ALD, but the underlying mechanisms driving macrophage polarization and their functionality in ALD are complex. In this review, we explore the various populations of hepatic macrophages in alcohol-associated liver disease and the underlying mechanisms driving their polarization. Additionally, we summarize the crosstalk between hepatic macrophages and other hepatic cell types in ALD, in order to support the exploration of targeted therapeutics by modulating macrophage polarization.
Keywords: alcohol; cirrhosis; fibrosis; liver disease; macrophages.
© 2023 Ait Ahmed et al.
Conflict of interest statement
FT’s lab has received research funding from Allergan, Bristol-Myers Squibb, Gilead and Inventiva. FT has received honoraria for consulting or lectures from Astra Zeneca, Gilead, AbbVie, BMS, Boehringer, Madrigal, Intercept, Falk, Ionis, Inventiva, Merz, Pfizer, Alnylam, NGM, CSL Behring, Novo Nordisk, Novartis. The other authors report no conflicts of interest in this work.
Figures


Similar articles
-
Alcoholic liver disease: A current molecular and clinical perspective.Liver Res. 2018 Dec;2(4):161-172. doi: 10.1016/j.livres.2018.11.002. Epub 2018 Dec 12. Liver Res. 2018. PMID: 31214376 Free PMC article.
-
Alcoholic Hepatitis: A Review.Alcohol Alcohol. 2019 Jul 1;54(4):408-416. doi: 10.1093/alcalc/agz036. Alcohol Alcohol. 2019. PMID: 31219169 Free PMC article. Review.
-
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.Int J Mol Sci. 2023 Feb 13;24(4):3735. doi: 10.3390/ijms24043735. Int J Mol Sci. 2023. PMID: 36835145 Free PMC article. Review.
-
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7. Exp Mol Pathol. 2017. PMID: 28077318 Review.
-
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?World J Gastroenterol. 2016 Jan 7;22(1):50-71. doi: 10.3748/wjg.v22.i1.50. World J Gastroenterol. 2016. PMID: 26755860 Free PMC article. Review.
Cited by
-
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease.Cells. 2025 Jan 30;14(3):207. doi: 10.3390/cells14030207. Cells. 2025. PMID: 39936998 Free PMC article. Review.
-
Myeloid cells in chronic liver inflammation.Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4. Online ahead of print. Cell Mol Immunol. 2025. PMID: 40721870 Review.
-
Baicalin mitigates alcoholic-associated liver disease via SOCS1-driven reprogramming of macrophages.Chin Med. 2025 May 13;20(1):63. doi: 10.1186/s13020-025-01110-4. Chin Med. 2025. PMID: 40361210 Free PMC article.
-
Peanut Shell Extract Improves Mitochondrial Function in db/db Mice via Suppression of Oxidative Stress and Inflammation.Nutrients. 2024 Jun 21;16(13):1977. doi: 10.3390/nu16131977. Nutrients. 2024. PMID: 38999726 Free PMC article.
-
Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics.Livers. 2024 Sep;4(3):455-478. doi: 10.3390/livers4030033. Epub 2024 Sep 13. Livers. 2024. PMID: 39328386 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources